Display options
Cite
Thomazzi SM, Ribeiro RA, Campos DI, et al. Tumor necrosis factor, interleukin-1 and interleukin-8 mediate the nociceptive activity of the supernatant of LPS-stimulated macrophages. Mediators Inflamm. 1997;6(3):195-200doi: 10.1080/09629359791686.
Thomazzi, S. M., Ribeiro, R. A., Campos, D. I., Cunha, F. Q., & Ferreira, S. H. (1997). Tumor necrosis factor, interleukin-1 and interleukin-8 mediate the nociceptive activity of the supernatant of LPS-stimulated macrophages. Mediators of inflammation, 6(3), 195-200. https://doi.org/10.1080/09629359791686
Thomazzi, S M, et al. "Tumor necrosis factor, interleukin-1 and interleukin-8 mediate the nociceptive activity of the supernatant of LPS-stimulated macrophages." Mediators of inflammation vol. 6,3 (1997): 195-200. doi: https://doi.org/10.1080/09629359791686
Thomazzi SM, Ribeiro RA, Campos DI, Cunha FQ, Ferreira SH. Tumor necrosis factor, interleukin-1 and interleukin-8 mediate the nociceptive activity of the supernatant of LPS-stimulated macrophages. Mediators Inflamm. 1997;6(3):195-200. doi: 10.1080/09629359791686. PMID: 18472820; PMCID: PMC2365829.
Copy Download .nbib Format: NLM
Share it on

Mediators Inflamm. 1997;6(3):195-200. doi: 10.1080/09629359791686.

Tumor necrosis factor, interleukin-1 and interleukin-8 mediate the nociceptive activity of the supernatant of LPS-stimulated macrophages.

Mediators of inflammation

S M Thomazzi, R A Ribeiro, D I Campos, F Q Cunha, S H Ferreira

Affiliations

  1. Department of Physiology and Pharmacology Center of Health Sciences Federal University of Ceará Fortaleza CE 60430-270 Brazil.

PMID: 18472820 PMCID: PMC2365829 DOI: 10.1080/09629359791686

Abstract

It has been suggested that the supernatant of LPSstimulated macrophages (macrophage nociceptive factor, MNF) promotes nociception in mice. Intraperitoneal administration of MNF induced dose-related writhing, which reached a plateau between 18 and 26 min after injection and decreased within 60 min. The release of MNF was inhibited by the pretreatment of the macrophages with cycloheximide, a protein synthesis inhibitor, or with the glucocorticoid dexamethasone. Cyclooxygenase inhibitors, such as indomethacin or paracetamol, had no effect. The MNF-induced nociception was inhibited in a dose-related manner by pretreatment of the animals with indomethacin, paracetamol or dexamethasone. Pretreatment of the animals with the sympatholytics guanethidine and atenolol partially reduced the MNF nociception, which was abolished by the combination of guanethidine or atenolol with indomethacin. The preincubation of MNF with antisera against TNF-alpha, IL-1 or IL-8 partially inhibited its nociceptive effect. Intraperitoneal injection of a mixture of the recombinants cytokines TNF-alpha, IL-1 and IL-8 mimicked MNF nociception. The individual injection of these cytokines was unable to induce the nociceptive effect. In conclusion, our data suggest that the nociceptive activity of the supernatant of LPSstimulated macrophages is explained by the presence of TNF-alpha, IL-1 and IL-8, the nociceptive activity of which (in mice) seems to be due to the release of cyclooxygenase and sympathetic metabolites.

References

  1. Nature. 1980 Sep 11;287(5778):147-9 - PubMed
  2. Br J Pharmacol. 1991 Nov;104(3):765-7 - PubMed
  3. Br J Pharmacol Chemother. 1968 Feb;32(2):295-310 - PubMed
  4. Braz J Med Biol Res. 1988;21(2):341-3 - PubMed
  5. Cancer Res. 1990 Sep 1;50(17):5537-42 - PubMed
  6. Mol Cell Biochem. 1995 Jul 19;148(2):105-13 - PubMed
  7. Agents Actions. 1990 Jun;30(3-4):344-9 - PubMed
  8. J Immunol Methods. 1989 Jan 17;116(2):259-64 - PubMed
  9. Nature. 1988 Aug 25;334(6184):698-700 - PubMed
  10. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3228-32 - PubMed
  11. Br J Pharmacol. 1992 Nov;107(3):660-4 - PubMed
  12. Mediators Inflamm. 1993;2(6):435-42 - PubMed
  13. J Infect Dis. 1991 Jun;163(6):1177-84 - PubMed
  14. Br J Pharmacol. 1988 Aug;94(4):987-1015 - PubMed
  15. Immunology. 1991 Aug;73(4):472-7 - PubMed
  16. Braz J Med Biol Res. 1988;21(3):565-8 - PubMed
  17. Eur J Pharmacol. 1987 Mar 17;135(2):145-53 - PubMed

Publication Types